Session Type
Meeting
Search Results for Alcohol
Plenary Presentations
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: There were nearly 33,000 admissions to Department of Veterans Affairs hospitals for alcohol withdrawal syndrome (AWS) in fiscal year 2017. Symptom-triggered management is the standard of care and, when employed effectively, the number of medication doses during admission is a good proxy for clinical severity of withdrawal. Several evidence-based algorithms for outpatient management of […]
Plenary Presentations
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: There were nearly 33,000 admissions to Department of Veterans Affairs hospitals for alcohol withdrawal syndrome (AWS) in fiscal year 2017. Symptom-triggered management is the standard of care and, when employed effectively, the number of medication doses during admission is a good proxy for clinical severity of withdrawal. Several evidence-based algorithms for outpatient management of […]
Abstract Number: 20
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Alcohol withdrawal is a common disorder faced by hospitalists. The pharmacologic standard of care involves the use of benzodiazepines, administered either as fixed doses or with doses adjusted per patient symptoms. At our institution, the alcohol withdrawal protocol previously in place used an institution-specific scale to evaluate patient symptoms, and nurses had latitude within […]
Abstract Number: 41
SHM Converge 2023
Background: Alcohol use disorder (AUD) is the most prevalent substance use disorder, but most patients with AUD do not receive evidence-based medications for AUD (MAUD), including naltrexone or acamprosate. Inpatient addiction consult services (ACS) may offer an opportunity to start medical treatment for hospitalized patients with AUD, but it is unknown if ACS are associated […]
Abstract Number: 44
SHM Converge 2023
Background: Alcohol withdrawal is a common issue in hospitalized patients and is associated with significant morbidity and mortality. Alcohol withdrawal occurs when the gamma aminobutyric acid (GABA) stimulating effect of alcohol is removed, resulting in an excess of the excitatory neurotransmitter glutamate. Treatment typically consists of as needed benzodiazepines, which activate GABA. However, this reactive […]
Abstract Number: 89
Hospital Medicine 2020, Virtual Competition
Background: It is estimated that 20% of patients who encounter the ED suffer from Alcohol Use Disorder (AUD) . Hospitalists encounter many Alcohol Withdrawal admissions and are often tasked with providing short counseling sessions on AUD due to time restraints. Furthermore, up to 50% of of patents admitted for Alcohol withdrawal will be readmitted for […]
Abstract Number: A8
SHM Converge 2022
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is defined as the presence of ≥5% of hepatic steatosis (HS) in the absence of other liver disorders, such as chronic viral or autoimmune hepatitis, steatosis induced by drugs, significant alcohol consumption, hemochromatosis, or Wilson’s disease. There is limited literature describing national prevalence and epidemiological characteristics of NAFLD in […]
Abstract Number: 101
Hospital Medicine 2020, Virtual Competition
Background: Alcoholic hepatitis (AH) related admissions have been increasing, and severe AH (as defined by a discriminant function [DF] > 32) can carry a one-month mortality rate of up to 50% (Crabb et al). With rising mortality from alcoholic liver disease, early detection of alcohol use disorder to achieve cessation and prevent progression to alcoholic […]
Abstract Number: 131
SHM Converge 2023
Background: Management of heart failure (HF) patients revolves around optimization of guideline directed medical therapy (GDMT) and routine monitoring. Substance use plays a major role as the etiology of HF, especially in a low socioeconomic area with ethnic and racial minority patients. The aim of this study is to find the correlation of alcohol, tobacco […]
Abstract Number: 135
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Acute alcohol withdrawal syndrome (AWS) is a common complication in hospitalized patients, but its occurrence and severity is difficult to predict based on clinical indicators alone. Phosphatidylethanol (PEth) is an abnormal phospholipid incorporated into erythrocyte lipid bilayers in proportion to levels of alcohol exposure, with a half-life of 5 to 10 days. We sought […]